Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci.

PubWeight™: 2.01‹?› | Rank: Top 2%

🔗 View Article (PMC 2187982)

Published in J Exp Med on December 01, 1985


W C Watson, A S Townes

Articles citing this

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest (2006) 3.51

Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med (1998) 3.20

Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc Natl Acad Sci U S A (2003) 2.80

Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. J Immunol (2007) 2.62

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A (1986) 2.27

N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol (2011) 2.18

Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med (2002) 1.94

Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A (1995) 1.71

Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology (1992) 1.63

Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest (2000) 1.62

The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology (2001) 1.49

Distinct cell-specific control of autoimmunity and infection by FcgammaRIIb. J Exp Med (2008) 1.43

VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest (1995) 1.43

CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. J Clin Invest (2003) 1.41

Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology (1988) 1.41

IFNgamma deficient C57BL/6 (H-2b) mice develop collagen induced arthritis with predominant usage of T cell receptor Vbeta6 and Vbeta8 in arthritic joints. Ann Rheum Dis (2003) 1.19

Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis. Ann Rheum Dis (1987) 1.14

CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol (1994) 1.09

Methotrexate ameliorates T cell dependent autoimmune arthritis and encephalomyelitis but not antibody induced or fibroblast induced arthritis. Ann Rheum Dis (2004) 1.05

A multiparameter approach to monitor disease activity in collagen-induced arthritis. Arthritis Res Ther (2010) 1.03

Expression of a transgenic T cell receptor beta chain enhances collagen-induced arthritis. J Exp Med (1992) 1.00

Resistance to development of collagen-induced arthritis in C57BL/6 mice is due to a defect in secondary, but not in primary, immune response. J Clin Immunol (2004) 1.00

Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin Exp Immunol (2002) 0.99

T-cell receptor V beta haplotype and complement component C5 play no significant role for the resistance to collagen-induced arthritis in the SWR mouse. Immunology (1991) 0.97

In vivo elimination of T cells expressing specific T-cell receptor V beta chains in mice susceptible to collagen-induced arthritis. Immunology (1990) 0.96

Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1997) 0.96

Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice. J Immunol (2008) 0.92

Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. J Clin Invest (2014) 0.91

Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis. Am J Pathol (2002) 0.91

Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis. Open Rheumatol J (2008) 0.87

Epitope specificity of antibody response against human type II collagen in the mouse susceptible to collagen-induced arthritis and patients with rheumatoid arthritis. Clin Exp Immunol (1988) 0.83

Gm allotypes and HLA in rheumatoid arthritis patients with circulating antibodies to native type II collagen. Ann Rheum Dis (1987) 0.81

The roles of interleukin-18 in collagen-induced arthritis in the BB rat. Clin Exp Immunol (2004) 0.81

Human HLA-DR beta gene hypervariable region homology in the biobreeding BB rat: selection of the diabetic-resistant subline as a rheumatoid arthritis research tool to characterize the immunopathologic response to human type II collagen. J Exp Med (1990) 0.81

Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis. Clin Exp Immunol (2011) 0.80

Contribution of the spleen, lymph nodes and bone marrow to the antibody response in collagen-induced arthritis in the rat. Clin Exp Immunol (1991) 0.80

JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis. Am J Pathol (2011) 0.79

K/BxN Serum-Transfer Arthritis as a Model for Human Inflammatory Arthritis. Front Immunol (2016) 0.79

Staphylococcal enterotoxin B increases the severity of type II collagen induced arthritis in mice. Ann Rheum Dis (1995) 0.78

Modulation of T cell proliferation and cytokine response by Plumbagin, extracted from Plumbago zeylanica in collagen induced arthritis. BMC Complement Altern Med (2011) 0.77

Arthrogenicity of type II collagen monoclonal antibodies associated with complement activation and antigen affinity. J Inflamm (Lond) (2011) 0.76

Altered influenza virus haemagglutinin (HA)-derived peptide is potent therapy for CIA by inducing Th1 to Th2 shift. Cell Mol Immunol (2011) 0.75

Low-affinity antibodies against collagen type II produced by lymph node cells are associated with pathology in collagen-induced arthritis in rats. Clin Exp Immunol (1992) 0.75

Articles cited by this

Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56

Enzyme immunoassays in diagnostic medicine. Theory and practice. Bull World Health Organ (1976) 12.01

Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09

Genetic control of specific immune responses. Adv Immunol (1969) 8.81

Immunisation against heterologous type II collagen induces arthritis in mice. Nature (1980) 7.08

Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med (1981) 5.76

Deficiency of the fifth component of complement in mice with an inherited complement defect. J Exp Med (1967) 3.28


Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71

Macrophage activation selectively enhances expression of Fc receptors for IgG2a. J Exp Med (1983) 1.63

Isotypes of mouse IgG--I. Evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement. Mol Immunol (1980) 1.59

Native type II collagen--induced arthritis in the rat: the effect of complement depletion by cobra venom factor. Arthritis Rheum (1981) 1.57

Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48

Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin. Arthritis Rheum (1983) 1.42

Isotype-specific T cell regulation of immunoglobulin expression. Immunol Rev (1982) 1.18

Immunogenicity of antigen complexed with antibody. I. Role of different isotypes. Immunology (1982) 1.03

IgG subclasses in collagen-induced arthritis in the rat. Immunol Lett (1984) 1.00

Autoimmune thyroiditis: conversion of low-responder mice to high-responders by cyclophosphamide. Clin Exp Immunol (1982) 0.91

Articles by these authors

Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09

Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06

Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84

Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79

Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29

Health care abuse. CMAJ (1994) 2.22

Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16

Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10

Lymphocytes in Whipple's disease. Lancet (1968) 2.06

Aortoenteric fistula. Incidence, presentation recognition, and management. Ann Surg (1982) 1.97

Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71

Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55

Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52

The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein. J Clin Invest (1971) 1.51

Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51

Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49

Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48

Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43

Hypertonicity of the cricopharyngeal sphincter: A cause of globus sensation. Lancet (1974) 1.41

Globus and headache: common symptoms of the irritable bowel syndrome. Can Med Assoc J (1978) 1.35

Topics in clinical medicine. Complement levels in disease. Johns Hopkins Med J (1967) 1.29

Intestinal disaccharidase activity in rosacea. Br Med J (1966) 1.28

Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol (1992) 1.22

Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21

Preliminary criteria for the classification of systemic lupus erythematosus (SLE). Evaluation in early diagnosed SLE and rheumatoid arthritis. Arthritis Rheum (1974) 1.16

Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science (1982) 1.16

Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum (1987) 1.14

Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12

Collagen autoimmunity and arthritis. FASEB J (1988) 1.11

Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med (1975) 1.09

Studies on intestinal pH by radiotelemetering. Gut (1965) 1.09

Chronic intestinal ischaemia. Br Med J (1967) 1.08

Epigastric bruits in patients with and without celiac axis compression. A phonoarteriographic study. Ann Intern Med (1973) 1.08

Celiac axis compression: experience with 20 patients and a critical appraisal of the syndrome. Ann Intern Med (1977) 1.05

Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol (1983) 1.04

Controlled trial of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum (1976) 1.04

Abdominal pain in a mixed adult African population: diagnosis on first presentation. J Trop Med Hyg (1968) 1.01

Bacterial L-form isolation from inflammatory bowel disease patients. Gastroenterology (1983) 0.99

Alkaline phosphatase levels in normal and diseased small bowel. Gut (1968) 0.98

Radiologic recommendations in cases of gastric ulcer. CMAJ (1993) 0.98

Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol (1976) 0.98

Type II collagen-induced autoimmune otospongiosis. A preliminary report. Ann Otol Rhinol Laryngol (1983) 0.97

Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum (1981) 0.97

Management of adenocarcinoma in a columnar-lined esophagus. Ann Thorac Surg (1985) 0.97

The role of collagen autoimmunity in animal models and human diseases. J Invest Dermatol (1982) 0.95

Detection and quantitation of tetanus antitoxin in blood donations. J Clin Pathol (1975) 0.95

Direct vision of the ampulla of Vater through the gastroduodenal fiberscope. Lancet (1966) 0.95

Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum (1986) 0.93

Arthritis in viral hepatitis. Report of two cases and review of the literature. Johns Hopkins Med J (1973) 0.92

Autoantibodies to murine type II collagen in collagen-induced arthritis: a comparison of susceptible and nonsusceptible strains. J Immunol (1996) 0.92

Radiotelemetering studies of jejunal pH before and after vagotomy and gastro-enterostomy. Gut (1966) 0.92

"Bingo brain". Can Med Assoc J (1982) 0.91

Phonoenterography: the recording and analysis of bowel sounds. Gut (1967) 0.89

Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol (1993) 0.89

Duplication of the ileum with heterotopic gastric mucosa pseudomyxoma peritonei and nonrotation of the midgut. Gastroenterology (1974) 0.89

Complement in synovial fluid. Johns Hopkins Med J (1970) 0.89

Complement-fixing activity of rheumatoid synovial fluid. Ann Rheum Dis (1972) 0.88

Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig. J Immunol (1976) 0.88

SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies. Arthritis Rheum (1991) 0.87

Limiting initial resuscitation of uncontrolled hemorrhage reduces internal bleeding and subsequent volume requirements. J Trauma (1995) 0.86

Fat digestion and absorption in the adrenalectomized rat. J Lipid Res (1966) 0.86

Aortoduodenal fistula; endoscopic diagnosis. Dig Dis Sci (1980) 0.86

Collagen-induced arthritis in rats. Examination of the epitope specificities of circulating and cartilage-bound antibodies produced by outbred and inbred rats using cyanogen bromide-derived peptides purified from heterologous and homologous type II collagens. J Immunol (1992) 0.85

Outcome of moderate carotid artery stenosis in patients who are asymptomatic. J Vasc Surg (1999) 0.85

Partial dissociation of rheumatoid synovial fluid cryoprotein: micro-complement fixation by IgG- or IgG and IgM-containing fractions and denatured calf thymus DNA. J Immunol (1971) 0.84

Type II collagen-induced arthritis. Ann N Y Acad Sci (1985) 0.84

Immunity to type XI collagen in mice. Evidence that the alpha 3(XI) chain of type XI collagen and the alpha 1(II) chain of type II collagen share arthritogenic determinants and induce arthritis in DBA/1 mice. J Immunol (1991) 0.84

Chest pain--esophageal, cardiac, or both? Am J Gastroenterol (1985) 0.84

Coeliac-axis compression. Lancet (1977) 0.84

Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis. Clin Exp Immunol (1990) 0.84

Hypergastrinemia and gastric acid hypersecretion in uremia. Clin Nephrol (1976) 0.84

Proceedings: Impaired cell-mediated immunity in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Arthritis Rheum (1974) 0.83

Rgulation of intestinal alkaline phosphatase levels in the rat. Role of the adrenal cortex. J Clin Pathol (1967) 0.82

Does cimetidine cause ileus in the burned patient? Lancet (1977) 0.82

Physicochemical and immunological studies of the renatured alpha 1(II) chains and isolated cyanogen bromide peptides of type II collagen. Coll Relat Res (1985) 0.82

Collagen-induced arthritis in rodents. A review of clinical, histological and immunological features. Ryumachi (1984) 0.81

Carotid endarterectomy for recurrent stenosis. J Vasc Surg (1997) 0.81

Identification of Neisseria gonorrhoeae in synovial membrane by electron microscopy. J Infect Dis (1974) 0.81

The immune response of guinea-pigs to type II collagen: poor cross-reactivity with homologous type II collagen accounts for resistance to collagen-induced arthritis. Immunology (1988) 0.81

Carnosinase activity of human gastrointestinal mucosa. Gut (1975) 0.80

Intra-aortic balloon counterpulsation in patients with severe cardiac dysfunction undergoing abdominal operations. Arch Surg (1998) 0.79

Autoantibodies to type II collagen. Mayo Clin Proc (1984) 0.79

Letter: Cause of adult toxic epidermal necrolysis. N Engl J Med (1975) 0.79

Lymphocyte surface markers in human disease. Adv Intern Med (1977) 0.78

The effect of gastric secretory status on jejunal pH measured by radiotelemetering. Digestion (1971) 0.78

Lymphocytes in Whipple's disease. Proc R Soc Med (1969) 0.78

Pulmonary hypertension due to micro-thromboembolism from splenic and portal veins after portacaval anastomosis. Br Heart J (1970) 0.78

Immunity to type IX collagen in rodents: a study of type IX collagen for autoimmune and arthritogenic activities. Clin Exp Immunol (1998) 0.77

Prostaglandin E2 tablets prevent aspirin-induced blood loss in man. Dig Dis Sci (1982) 0.77

Immunopathogenic mechanisms in type II collagen autoimmune arthritis. Pathol Immunopathol Res (1986) 0.77

Failure of calcitonin to inhibit collagen-induced arthritis in rats. Agents Actions (1982) 0.76

Hypertonic acetate dextran achieves high-flow-low-pressure resuscitation of hemorrhagic shock. J Trauma (1995) 0.76

Acute effects of intermittent pneumatic compression on popliteal artery blood flow. Arch Surg (1998) 0.76

The Xylum Clot Signature Analyzer: a dynamic flow system that simulates vascular injury. Thromb Res (1998) 0.76

Radiotelemetering studies of jejunal pH before and after vagotomy and pyloroplasty. Gut (1968) 0.76